Details

Guidelines for Preparation of New Drug Submissions for Products Used for Estrogen-Progestin Replacement Therapy in Menopause (HRT) - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Jan 3, 2026 · edition #6
Timestamp: 2026-01-03T14:16:17.671Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/hormone-replacement-therapy/guidelines-preparation-new-drug-submissions-products-used-estrogen-progestin-replacement-therapy-menopause.html?wbdisable=false
Replay URL: https://replay.healtharchive.ca/job-6/20260103141617/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/hormone-replacement-therapy/guidelines-preparation-new-drug-submissions-products-used-estrogen-progestin-replacement-therapy-menopause.html?wbdisable=false#ha_snapshot=447356
ID: 447356
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots